Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary P Wormser

Showing results (51-60 of 312) with videos related to

Pageof 32
Sort By:
The Lancet. Infectious Diseases|December 24, 2016
Prophylaxis with topical azithromycin against Lyme borreliosisEugene D Shapiro, Gary P Wormser
Journal of Women'S Health (2002)|June 12, 2009
Implications of gender in chronic Lyme diseaseGary P Wormser, Eugene D Shapiro
The Journal of Infectious Diseases|July 25, 2024
Reply to Dow and SmithChoukri Ben Mamoun, Gary P Wormser
Pathogens (Basel, Switzerland)|September 23, 2022
Failure of an Approximately Six Week Course of Tafenoquine to Completely Eradicate <i>Babesia microti</i> Infection in an Immunocompromised PatientPrithiv J Prasad, Gary P Wormser
Arthritis & Rheumatology (Hoboken, N.J.)|June 27, 2014
Review: unraveling Lyme diseaseLinda K Bockenstedt, Gary P Wormser
The New England Journal of Medicine|December 12, 2019
NeurosyphilisGary P Wormser, Charles S Pavia
JAMA|August 4, 2018
Lyme Disease in 2018: What Is New (and What Is Not)Eugene D Shapiro, Gary P Wormser
The American Journal of Medicine|June 15, 2014
Chronic coinfections in patients diagnosed with chronic lyme disease: a systematic reviewPaul M Lantos, Gary P Wormser
Open Forum Infectious Diseases|August 4, 2023
Relapsing Babesiosis With Molecular Evidence of Resistance to Certain Antimicrobials Commonly Used to Treat <i>Babesia microti</i> InfectionsLuis A Marcos, Gary P Wormser
Wiener Klinische Wochenschrift|May 12, 2019
Evaluation of the clinical relevance of vancomycin for the treatment of Lyme diseaseGary P Wormser, Alan G Barbour
Pageof 32

Showing results (51-60 of 312) with videos related to

Sort By:
Pageof 32
The Lancet. Infectious Diseases|December 24, 2016
Prophylaxis with topical azithromycin against Lyme borreliosisEugene D Shapiro, Gary P Wormser
Journal of Women'S Health (2002)|June 12, 2009
Implications of gender in chronic Lyme diseaseGary P Wormser, Eugene D Shapiro
The Journal of Infectious Diseases|July 25, 2024
Reply to Dow and SmithChoukri Ben Mamoun, Gary P Wormser
Pathogens (Basel, Switzerland)|September 23, 2022
Failure of an Approximately Six Week Course of Tafenoquine to Completely Eradicate <i>Babesia microti</i> Infection in an Immunocompromised PatientPrithiv J Prasad, Gary P Wormser
Arthritis & Rheumatology (Hoboken, N.J.)|June 27, 2014
Review: unraveling Lyme diseaseLinda K Bockenstedt, Gary P Wormser
The New England Journal of Medicine|December 12, 2019
NeurosyphilisGary P Wormser, Charles S Pavia
JAMA|August 4, 2018
Lyme Disease in 2018: What Is New (and What Is Not)Eugene D Shapiro, Gary P Wormser
The American Journal of Medicine|June 15, 2014
Chronic coinfections in patients diagnosed with chronic lyme disease: a systematic reviewPaul M Lantos, Gary P Wormser
Open Forum Infectious Diseases|August 4, 2023
Relapsing Babesiosis With Molecular Evidence of Resistance to Certain Antimicrobials Commonly Used to Treat <i>Babesia microti</i> InfectionsLuis A Marcos, Gary P Wormser
Wiener Klinische Wochenschrift|May 12, 2019
Evaluation of the clinical relevance of vancomycin for the treatment of Lyme diseaseGary P Wormser, Alan G Barbour
Pageof 32